Aberdeen Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Buy |
844,705
+25,228
| +3% | +$404K | 0.02% | 528 |
|
|
2025
Q1 | $14M | Buy |
819,477
+287,367
| +54% | +$4.91M | 0.03% | 479 |
|
|
2024
Q4 | $13.2M | Buy |
532,110
+53,353
| +11% | +$1.32M | 0.02% | 456 |
|
|
2024
Q3 | $13.6M | Buy |
478,757
+78,035
| +19% | +$2.22M | 0.03% | 459 |
|
|
2024
Q2 | $10.6M | Buy |
400,722
+213,086
| +114% | +$5.63M | 0.02% | 502 |
|
|
2024
Q1 | $6.06M | Sell |
187,636
-140,070
| -43% | -$4.53M | 0.01% | 637 |
|
|
2023
Q4 | $13.8M | Buy |
+327,706
| New | +$13.8M | 0.03% | 483 |
|